Correlation Between Fusion Pharmaceuticals and GH Research
Can any of the company-specific risk be diversified away by investing in both Fusion Pharmaceuticals and GH Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fusion Pharmaceuticals and GH Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fusion Pharmaceuticals and GH Research PLC, you can compare the effects of market volatilities on Fusion Pharmaceuticals and GH Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fusion Pharmaceuticals with a short position of GH Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fusion Pharmaceuticals and GH Research.
Diversification Opportunities for Fusion Pharmaceuticals and GH Research
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Fusion and GHRS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fusion Pharmaceuticals and GH Research PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GH Research PLC and Fusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fusion Pharmaceuticals are associated (or correlated) with GH Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GH Research PLC has no effect on the direction of Fusion Pharmaceuticals i.e., Fusion Pharmaceuticals and GH Research go up and down completely randomly.
Pair Corralation between Fusion Pharmaceuticals and GH Research
If you would invest 709.00 in GH Research PLC on October 25, 2024 and sell it today you would earn a total of 171.00 from holding GH Research PLC or generate 24.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 5.56% |
| Values | Daily Returns |
Fusion Pharmaceuticals vs. GH Research PLC
Performance |
| Timeline |
| Fusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| GH Research PLC |
Fusion Pharmaceuticals and GH Research Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fusion Pharmaceuticals and GH Research
The main advantage of trading using opposite Fusion Pharmaceuticals and GH Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fusion Pharmaceuticals position performs unexpectedly, GH Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GH Research will offset losses from the drop in GH Research's long position.| Fusion Pharmaceuticals vs. Bicycle Therapeutics | Fusion Pharmaceuticals vs. Relmada Therapeutics | Fusion Pharmaceuticals vs. RAPT Therapeutics | Fusion Pharmaceuticals vs. NewAmsterdam Pharma |
| GH Research vs. Molecular Partners AG | GH Research vs. MediciNova | GH Research vs. Anebulo Pharmaceuticals | GH Research vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |